Fair Value Calculator Fair Value Calculator
EN DE

URSUGAR (URSUGAR) Fair Value & Analysis

IN · Market cap ₹150M

U URSUGAR URSUGAR · BSE
Price₹2.92
Fair Value₹1.69
Upside-42.1%
Quality58/100
Watch URSUGAR for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range ₹1.27 – ₹2.11

Fair value as of: Jul 6, 2026

From 6 valuation models · updated today

Share price +1.4% over the past month.

Price vs Fair Value (12 months)

₹6.85 ₹1.94 Fair Value ₹1.69 Jun 2025 Jul 2026

12‑month range ₹1.94 – ₹6.85 · fair‑value band ₹1.27 – ₹2.11 · the ₹2.92 price screens above the ₹1.69 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

URSUGAR (URSUGAR) currently trades at ₹2.92, while our model-based Fair Value estimate is ₹1.69 — implying the stock looks roughly 42.1% overvalued today. We read business quality at 58/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, URSUGAR generated revenue of ₹9.5M at a net margin of 46.9%. Revenue declined 34.6% year over year. It earns a return on equity of 2.4%. The stock trades on a trailing P/E of 35.6. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹1.27 (bear case) to ₹2.11 (bull case); at ₹2.92, the current price sits above that range. The share trades about 58% below its 52-week high and 61% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹9.5M
Revenue growth (YoY) -34.6%
Net margin 46.9%
Return on equity 2.4%
Free cash flow −₹6.9M FY2026
P/E ratio 35.6
More key figures
Operating margin 61.2%
EPS (TTM) ₹0.0800
EPS growth (YoY) -50.0%

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

URSUGAR reported revenue of ₹0 in FY2026 versus ₹67.9M in FY2022. Reported net income was ₹4.4M in FY2026, compounding −25.9%/yr from FY2022.

Revenue
FY22 ₹67.9M
FY23 ₹90.7M
FY24 ₹0
FY25 ₹0
FY26 ₹0
Net income −25.9%/yr
FY22 ₹14.7M
FY23 −₹2.2M
FY24 ₹5.6M
FY25 ₹4.2M
FY26 ₹4.4M

Is URSUGAR fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "URSUGAR Fair Value". https://www.fairvalue-calculator.com/stock/URSUGAR

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is URSUGAR (URSUGAR) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹1.69 versus a price of ₹2.92 — about −42% (overvalued). Model-based estimate, not financial advice.
What is the fair value of URSUGAR?
Our model-based fair value for URSUGAR is ₹1.69 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹2.92.
What is the quality score of URSUGAR?
URSUGAR has a Quality Score of 58/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of URSUGAR (URSUGAR)?
URSUGAR reported trailing-twelve-month revenue of about ₹9.5M (latest available figure, as of Jul 6, 2026).
What is the net profit margin of URSUGAR?
The net profit margin of URSUGAR is about 46.9%, meaning it keeps roughly 46.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.